Cargando…
Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model
Left atrial appendage (LAA) closure is being developed as an alternative for stroke prevention in patients with atrial fibrillation that cannot tolerate long-term oral anticoagulation. To assess the feasibility, safety, and performance of a novel modified Occlutech LAA closure device in a preclinica...
Autores principales: | Reinthaler, Markus, Grosshauser, Johannes, Schmidt, Tanja, Unger, Juliane, Morgan, Ross, Zimmermann, Friederike, Hartung, Johannes, Seppelt, Claudio, Meteva, Denitsa, Haider, Wolfram, Landmesser, Ulf, Skurk, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862256/ https://www.ncbi.nlm.nih.gov/pubmed/33542297 http://dx.doi.org/10.1038/s41598-021-82359-1 |
Ejemplares similares
-
Safety and Healthcare Resource Utilization in Patients Undergoing Left Atrial Appendage Closure—A Nationwide Analysis
por: Thevathasan, Tharusan, et al.
Publicado: (2023) -
Rapid Inflammasome Activation Is Attenuated in Post-Myocardial Infarction Monocytes
por: Giral, Hector, et al.
Publicado: (2022) -
Transcatheter Atrial Septal Defect Closure Using Occlutech Figulla Device: A Two-Center Experience
por: Mortezaeian, Hojat, et al.
Publicado: (2013) -
Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla(®) Flex II Occluder
por: Neuser, Jonas, et al.
Publicado: (2016) -
Patent ductus arteriosus closure using Occlutech(®) Duct Occluder, experience in Port Elizabeth, South Africa
por: Pepeta, Lungile, et al.
Publicado: (2017)